<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Research

Research    Faculty    Pharmacy

Treatment Gets Personal with Advances in Precision Medicine

Is there a way to reduce the time spent in trialing different medications, such as antidepressants? Is there a way to predict who may be at increased risk of experiencing medication side effects?


Author Jordan Kellerman | Publish Date June 21, 2021
Full Story

Research    Alumni    Pharmacy    Clinical Research    Graduate Program

CU Pharmacy Alumnus Strategizes through PhD Program


Recently, we connected with Dr. Chong Kim (CK), who received his PhD in Pharmaceutical Outcomes during the fall 2020 Commencement on Dec. 12. Dr. Kim  describes himself as a critical thinking, highly motivated, and hard working problem solver. Currently, his specific interests lie in optimizing the landscape of the healthcare environment around the world. His main expertise involves observational studies, development of statistical methods, and programming. He's currently working as a manager at Stratevi.

Author Jaron Bryant | Publish Date May 28, 2021
Full Story

Research    Students

Student Researchers Examine Infectious Disease Theory

Listening to Dr. Meghan Jeffres and her students explain their infectious disease work brings to mind the 80’s arcade game Space Invaders, in which an intergalactic battle plays out between defending forces and evil alien elements. The researchers describe an inner world, specifically the large and small intestines, in which tricky bacteria use enzymatic mechanisms to destroy the antibiotic sent to destroy it. Welcome to the front line of the infectious disease battleground.


Author Lori Westermann | Publish Date May 17, 2021
Full Story

Research    Faculty    Students    Pharmacy

Persistence Pays Off

According to Kristofer Fritz, PhD, associate professor in the School of Pharmacy’s Pharmaceutical Sciences Department, bench-side research requires a lot of trial and error. Also, according to Dr. Fritz, it takes a certain kind of fortitude and dedication for a PharmD student to undertake an intensive lab-based research project due to the already-demanding academic rigors of a pharmacy degree.


Author Lori Westermann | Publish Date May 14, 2021
Full Story

Research    Faculty    neuroscience

New Study Reveals Medicare Payments Far Outpace Claims for Neurology Drugs

A new study of Medicare payments has found that over a five-year period, the payments for medications prescribed to people with neurologic conditions like multiple sclerosis (MS), Parkinson’s disease and epilepsy increased by 50% while the number of claims for these prescription medications only rose by only 8%. The study is published in the online issue of Neurology®, the medical journal of the American Academy of Neurology. The study, funded by the American Academy of Neurology, also found that most of the increase was due to rising costs for neuroimmunology drugs, mostly for multiple sclerosis.


Author SOP Communications | Publish Date March 24, 2021
Full Story

Research    Patient Care    Faculty    Pharmacy

Jeffres Publishes in JAMA Surgery Journal

New research from Dr. Meghan Jeffres, PharmD, Skaggs School of Pharmacy and Pharmaceutical Sciences, Massachusetts General Hospital (MGH), and University of Porto in Portugal, indicates that most surgical patients with a history of penicillin allergy can safely be given the guideline-recommended antibiotic cefazolin to prevent infection instead of alternative antibiotics that are less effective and more expensive. The researchers reported in JAMA Surgery that the frequency of allergies to both penicillins and cefazolin was so small that most patients should receive cefazolin regardless of their allergy history.


Author SOP Communications | Publish Date March 16, 2021
Full Story

Research    Pharmacy

Published Research Supports Expanding Insurance Coverage of Non-invasive Prenatal Testing

A new study by R. Brett McQueen, PhD, assistant professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, supports expanding coverage of non-invasive prenatal testing (NIPT) to pregnant women less than 35 years of age. 


Author cupharmacy | Publish Date March 12, 2021
Full Story

Research    Faculty

Peter Anderson chosen by peers for Shell Prize

Peter Anderson, PharmD, professor and Director of the Pharmaceutical Sciences Graduate Program, was named the 2020 recipient of the John and Barbara Shell Prize in Research and Graduate Education, the highest honor given by the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Initially started in 2002 as an annual award, this distinction is now presented every two years for outstanding achievement in research and graduate education. A committee of past recipients selects the recipient from among tenured professors in CU Pharmacy. 


Author Jordan Kellerman | Publish Date December 09, 2020
Full Story

Research   

The ALSAM Foundation Funds Breakthrough Robotic Screening and Imaging

We are pleased to announce that The ALSAM Foundation, a generous long-time benefactor to the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS), has provided an initial grant, which together with support from the Chancellor’s Office and the SSPPS, will fund a major new robotic high throughput/high content screening and imaging instrument for drug discovery and elucidation of new drug targets.


Author SOP Communications | Publish Date October 07, 2020
Full Story

Research    Faculty

Mallela partners with daughter to design artwork for muscular dystrophy research

Nimisha Mallela’s path as an artist has been on an upward trajectory ever since she started drawing at age seven. By 10, she completed some of her first full art pieces, and at 15, she began entering competitions. Her work has been published in student magazines and she even recently received first place in the Cherry Creek High School art competition with a painting of her grandmother.


Author Sara Knuth | Publish Date September 15, 2020
Full Story

Research    Faculty

Page leads major scientific statement on cannabis and heart health

University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Professor Robert Page, PharmD, MSPH, FAHA recently served as chair of an American Heart Association (AHA) writing group that found cannabis use shows substantial risks and no benefits for cardiovascular health. The group also says more research is critical. Below is a news release from the AHA.


Author SOP Communications | Publish Date August 31, 2020
Full Story

Research    Faculty    Students

CU Pharmacy first in Colorado to offer graduate-level cannabis education

Industry analysts say the market size of cannabinoid-based pharmaceuticals could generate up to $2 billion by the end of 2020 — and legal sales could earn up to $23 billion by 2025.


Author SOP Communications | Publish Date July 13, 2020
Full Story

Research    Faculty

In COVID-19 Battle, CU Anschutz Team Teaching Old Drugs New Tricks

As scientists around the world scramble against the COVID-19 clock, searching for a vaccine that could stop the viral infection before it happens, a trio of experts on the University of Colorado Anschutz Medical Campus have taken a different tack: overpowering the new mutation after it invades the body.


Author SOP Communications | Publish Date July 10, 2020
Full Story

Research    Community    Faculty

Clinical trial: How a CU Pharmacy professor's research is helping people with severe epilepsy

 

 

For patients with a severe form of epilepsy, it can be dangerous to drive, go to work or even walk to the mailbox alone. A fear of falling and blacking out prevents many patients with medically refractory epilepsy from living lives most people take for granted.

“They can’t have a job, they can’t really live a normal life,” said Tom Anchordoquy, PhD, professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. “These patients, before, had to always have someone with them because there was a fear of seizures.”

On top of that, the drugs patients with the severe form of epilepsy take to manage their disorder — which are needed in high concentrations in the brain — are typically taken orally and then distributed throughout the entire body, resulting in problematic side effects.


Author Sara Knuth | Publish Date July 01, 2020
Full Story

Research

Study pinpoints metrics of cost-effective screening for type 1 diabetes

AURORA, Colo.  – Health screenings can catch conditions early, helping patients avoid a condition’s worst consequences or even preventing it from developing altogether. Think of mammograms to catch breast cancer early or high blood pressure screening before a person has a stroke. Screening helps pre-symptomatic patients take actions to reduce their risk of a catastrophic outcome.


Author SOP Communications | Publish Date May 08, 2020
Full Story

Research    Community    Faculty

News roundup: CU Pharmacy faculty provides expertise during coronavirus pandemic


Associate Professor Sarah Anderson, PharmD, speaks with national news site Newsy about the coronavirus.

During the coronavirus pandemic, experts at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences can be counted on to answer some of the public's most pressing questions.

From working to develop a treatment to help COVID-19 patients to speaking about the impact on the U.S. drug supply, our faculty members are in the news.


Author Sara Knuth | Publish Date April 20, 2020
Full Story

Research    Faculty

Journal dedicated to professors John Carpenter and Ted Randolph

It wasn’t long after John Carpenter and Ted Randolph started working at the University of Colorado that a mutual friend and colleague suggested they collaborate.


Author Sara Knuth | Publish Date February 03, 2020
Full Story

Research    Community    Faculty    Alumni

Dr. Glenn Appelt’s legacy of generosity lives on with new CU Pharmacy scholarship in his name

If the late Dr. Glenn Appelt knew his wife and daughter would establish a scholarship in his name at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, he would have been proud to see a new generation of students have the opportunity to study pharmacy, says his wife of 30 years, Jennifer Appelt.


Author Sara Knuth | Publish Date December 20, 2019
Full Story

Research    Faculty

Faculty research evaluates innovative but costly cancer therapy in Journal of Clinical Oncology review article

After conducting pioneering research into the cost-effectiveness of an innovative new cancer treatment, researchers at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) were invited by the Journal of Clinical Oncology to contribute a review article in an upcoming special issue, “Economic Issues in Cancer Care.”


Author Sara Knuth | Publish Date December 12, 2019
Full Story

Research    Community    Faculty

CU Pharmacy professors weigh in on Denver’s historic psychedelic mushroom initiative

Denver made history this month by effectively decriminalizing psychedelic mushrooms — and experts at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences say the vote marks an important development for the drug, but only time will tell of its impact in a clinical setting.

The initiative, which passed by a close margin and was certified by the city of Denver on May 16, means that arresting anyone for personal possession, consumption or growth of “magic mushrooms” is a low priority for law enforcement. It also prohibits Denver from using city funds to prosecute similar cases.

Hallucinogenic mushrooms haven’t been fully legalized — and unlike marijuana, people won’t be able to legally buy and sell them in the city.


Author Sara Knuth | Publish Date May 16, 2019
Full Story

Research    Faculty

CU Pharmacy investigators receive PhRMA Foundation Award

The University of Colorado Center for Pharmaceutical Value (PValue) has been established with a Value Assessment Center of Excellence Award from the PhRMA Foundation.

The foundation grant of $500,000 was awarded to Jonathan Campbell, PhD, R. Brett McQueen, PhD, and Melanie Whittington, PhD, who have primary faculty appointments in the field of Pharmaceutical Outcomes Research with the Skaggs School of Pharmacy and Pharmaceutical Sciences on the Anschutz Medical Campus.

PValue will be a center of excellence within the D2V initiative, a Transformational Research Funding project supported by the Dean's Office of the University of Colorado School of Medicine. D2V will support PValue through a matching award of $500,000. Additional D2V support will include peer review, shared professional research assistance, project management expertise, and institutional accountability. The total award will be allocated over three years to establish PValue initiatives.


Author Caren Henderson | Publish Date January 22, 2019
Full Story

Research    Faculty

The ALSAM Foundation funds new Anschutz-Boulder collaborative research

The ALSAM Foundation, a generous long-time donor to the CU Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS), has provided $2M of funding for collaborative grants between the SSPPS and the BioFrontiers Institute. This donation supports the Therapeutic Innovation Grants Program that allows the SSPPS on the Anschutz Medical Campus to join forces with the BioFrontiers Institute on the Boulder Campus to encourage faculty collaboration in the development of innovative projects that will advance the health and wellness of people in our communities and around the globe. 


Author Caren Henderson | Publish Date December 17, 2018
Full Story

Research    Faculty

Personalized Cancer Treatment

According to the American Society of Clinical Oncology, more than 14 million people will be diagnosed with cancer this year, worldwide, and more than 9 million people will succumb to the effects of cancer. This is equal to approximately 22,000 cancer deaths per day, and this cancer mortality rate is expected to continue to rise.

Despite all the advances in technology to both diagnose and treat cancer, many of these therapies are ineffective against the later stages of cancer.


Author Stephanie Carlson | Publish Date November 25, 2018
Full Story

Research    Faculty

Faculty member Receives over $1 Million in NIH Funding

James Roede, PhD, an Assistant Professor in the Department of Pharmaceutical Sciences, was recently awarded two different Administrative Supplement Awards attached to his prestigious Outstanding New Environmental Scientist Award from NIEHS (National Institute of Environmental Health Sciences) - a division of NIH (National Institutes of Health).


Author Stephanie Carlson | Publish Date October 09, 2018
Full Story

Research

CU Pharmacy receives $2 million gift commitment

The ALSAM Foundation recently invested an additional $2 million to continue the Therapeutic Innovation Grants Program at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences.

The funding supports a second phase of grants for projects focused on drug discovery and development.


Author Stephanie Carlson | Publish Date September 20, 2018
Full Story

Research    Faculty

Edible Chemotherapy: Could particles from milk lead to the end of infusions?

Generally, you can't eat chemotherapy. That’s because your digestive system breaks down the molecules you eat into smaller pieces that can be absorbed through the gut into the bloodstream.


Author Stephanie Carlson | Publish Date August 08, 2018
Full Story

Research    Faculty

CU Pharmacy Research: Drug Prices not always Aligned with Value

In many countries, healthcare reimbursements for drugs are directly related to their value or net health benefits in treating disease.

But a new study by researchers at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with a group of international clinical and economic experts, shows that’s not the case in the U.S.


Author Stephanie Carlson | Publish Date August 07, 2018
Full Story

Research

Study: Drug Treatment to Inhibit Growth of Prostate Cancer Cells

Cancers are one of the leading causes of disease-related fatalities worldwide. Prostate cancer, in specific, affects about 6 out of 10 men over the age of 65. In US male population, it is most common malignancy after skin cancer and the second leading cause of cancer-related deaths. This highlights the need for immediate and effective prevention and intervention strategies.


Author Stephanie Carlson | Publish Date June 29, 2018
Full Story

Research    Students

Student Study: Access to emergency contraception in Arizona and Utah

It has taken all four years of pharmacy school but student Rupa Parikh has now completed her study on emergency contraception (also known as the morning after pill) availability, specifically in Arizona and Utah, and she’s getting a lot of recognition.


Author Stephanie Carlson | Publish Date January 29, 2018
Full Story

Research    Faculty

The Science Behind the Spicy Chip #OneChipChallenge

Just one chip, that's all it is, but it is a chip made with one of the hottest peppers on the planet. The Paqui Carolina Reaper Madness chip is made with the Carolina Reaper pepper, which has an average Scoville Scale score of over 1.5 million.


Author Stephanie Carlson | Publish Date December 27, 2017
Full Story

Research    Faculty

Expensive new cancer therapy may be cost effective

Researchers from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, selected to estimate the cost-effectiveness of the newly approved CAR-T therapies, have found the clinical benefit may justify the expensive price.


Author Stephanie Carlson | Publish Date December 21, 2017
Full Story

Research    Faculty

Study Results: Return on Investment of federal Prevention and Public Health Fund

University of Colorado researchers recently calculated the return on investment of one activity of the federal Prevention and Public Health Fund. Their study found that the activity has saved 35 million dollars since it was put into place in 2013.


Author Stephanie Carlson | Publish Date October 30, 2017
Full Story

Research    Faculty

Cannabis Studies

Faculty member Jacci Bainbridge, PharmD, together with Clinical Neurology Research Fellow Matt Makelky, PharmD, are currently studying cannabis and its effectiveness in treating a variety of conditions including back pain, Parkinson’s tremor and seizure disorders in children.

Some of the first prospective cannabis trials on the Anschutz Medical Campus “Will hopefully help determine the cannabis’ effectives in treating these types of disorders, side effects and dosing levels,” says Jacci Bainbridge.


Author cupharmacy | Publish Date October 18, 2017
Full Story

Research    Faculty

Faculty member finds natural compound to treat giardia and "brain-eating" infections

Used in Native American healing, some compounds in pungent plant stronger than available pharmaceutical treatments.


Author cupharmacy | Publish Date August 18, 2017
Full Story

Research    Students

Experiences and people do they lead to somewhere?

At my internship I shadow a lot of people. Many of them pharmacists, but some of them are researchers like James Griffon. I was in Dr. Simberg’s research laboratory shadowing James and I watched him go about his daily duties. The lab is a very different environment compared to some of the other settings I have shadowed. I always find my lab experience to be fun and relaxing. James is always doing something , so consequently, I'm always seeing something. Whether it be old or new, I find the lab work to be interesting. This time James was working with mice skin and freeze it on dry ice so that later they can slice it and get pictures of cells. He also transferred some cancer cells into new media, which kills an enzyme that attacks and kills the cancer cells.


Author cupharmacy | Publish Date May 08, 2017
Full Story

Research    Faculty

Faculty Member Selected As Scientist to Watch

James Roede among five early career scientists selected as ONES to watch

Recently, five researchers from universities throughout the country were selected as recipients of the competitive NIEHS (National Institute of Environmental Health Sciences) Outstanding New Environmental Health Science (ONES) awards. Faculty member James Roede was part of this illustrious group.

According to Roede, “This award gives me the opportunity to become truly independent and carve out my own niche in environmental health sciences.”


Author cupharmacy | Publish Date April 27, 2017
Full Story

Research    Faculty

Strengthening Exemptions Could Lower Risk of Measles Outbreak

Strengthening exemptions could boost vaccination coverage, reduce costs

States with weaker non-medical exemption policies for vaccinations can reduce the likelihood of a measles outbreak 140 to 190 percent by strengthening them, a new study from CU Skaggs School of Pharmacy and Pharmaceutical Sciences faculty member, Jon Campbell, PhD, show.


Author cupharmacy | Publish Date March 23, 2017
Full Story

Research    Students

Student Winter Symposium 2017

On January 18th, the Student Winter Symposium took place at CU Skaggs School of Pharmacy and Pharmaceutical Sciences. The involvement of the graduate students of the three PhD programs (Pharmaceutical sciences, Toxicology, Pharmaceutical outcomes research) at the School, as well as from the PharmD program was outstanding.


Author cupharmacy | Publish Date February 21, 2017
Full Story

Research    Faculty

Lotion repairs sun damage

Did you know that one in five Americans will develop skin cancer during their lifetime? University of Colorado (CU) scientists have developed a lotion that prevents and repairs sun damage.

“Most of us have damage just from being in the sun,” says Tom Anchordoquy, CU Skaggs School of Pharmacy and Pharmaceutical Sciences professor.


Author cupharmacy | Publish Date November 28, 2016
Full Story

Research    Students

Reveling in Research

The annual CU Skaggs School of Pharmacy and Pharmaceutical Sciences Seminar Research Poster Session put third-year students in the hot seat on Nov. 1 as they presented on topics they had been researching since their P2 year.


Author cupharmacy | Publish Date November 03, 2016
Full Story

Research    Students

Independent Study a Valuable Experience

Over the summer, I was fortunate enough to take part in an eye-opening learning experience at Kaiser Permanente Central Support Services. I applied for, and was accepted to participate in, a six-week-long managed care independent study worth two elective credits.


Author cupharmacy | Publish Date October 19, 2016
Full Story

Research    Faculty

Professor cautions heart failure linked to commonly used medications

University of Colorado Skaggs School of Pharmacy Professor Robert L. Page, PharmD, was the lead author on an American Heart Association (AHA) scientific statement cautioning patients and physicians that many commonly used medications and nutritional supplements may cause or worsen heart failure. Dr. Page was highlighted in many news outlets including CBSradio, CBS morning news, MedPage Today, the Daily Mirror and 9News.


Author cupharmacy | Publish Date September 29, 2016
Full Story

Research    Faculty

CU Pharmacy Researchers Develop New Test to Determine Adherence to HIV-drugs

CU Skaggs School of Pharmacy Professor Pete Anderson, PharmD, and lab manager Lane Bushman, together with colleagues, developed a technique that estimates an HIV-negative patient's adherence to drugs prescribed to prevent HIV transmission.  The test is being used in research internationally and could have widespread application for other drugs that require objective measurement of patient adherence to dosing.


Author cupharmacy | Publish Date August 29, 2016
Full Story

Research    Alumni

Married to Research

Cameron and Pallavi McElroy have been sharing their love for pharmacy and research since 2008 when they first met in their master’s of Pharmaceutical Sciences in Pharmacology and Toxicology program at the University of Toledo.


Author cupharmacy | Publish Date July 06, 2016
Full Story

Research    Faculty    Alumni

True Grit

Michael Cobretti’s got grit. At least, that’s what Dr. Christina Aquilante says.

Cobretti graduated from CU’s Skaggs School of Pharmacy in 2015 with a dream of doing a residency. But when it came time to match, the Walgreens pharmacy manager didn’t make the cut.


Author cupharmacy | Publish Date May 23, 2016
Full Story

Research    Students

Nano-scientist Tackles Nanoparticles

When 16-year-old Hari Sowrirajan says, “You can’t just buy nanoparticles at the supermarket,” you realize quickly that this down-to-earth high school student is doing some out-of-this-world science.

What you don’t know is that Sowrirajan has been working with researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences since he was a 13-year-old middle schooler—too young to step inside a CU Anschutz laboratory—all because he wrote a single email to a researcher he had never met.


Author cupharmacy | Publish Date April 20, 2016
Full Story

Research

$1 Million Gift from The ALSAM Foundation

From helping to build not one, but two school of pharmacy buildings -- one on the 9th Avenue campus and the other at the Anschutz Medical Campus -- to encouraging collaborative research between seven Skaggs institutions through the unique Skaggs Scholars Program that is centered at the University of Colorado, The ALSAM Foundation has been, and continues to be, a tremendous supporter of our school.


Author cupharmacy | Publish Date February 26, 2016
Full Story

Research    Faculty

Treating the Neglected?

Hepatitis C virus (HCV) treatment has been revolutionized by the recent approval of direct acting antiviral (DAA) therapies. These all-oral DAA therapies achieve high levels of HCV cure when taken as directed, but with a cost of $80,000+ for an entire course of treatment, the cure is expensive. So, who deserves the treatment?


Author cupharmacy | Publish Date February 17, 2016
Full Story

Research    Faculty

Love Lab

Viruses and bacteria aren’t the only things that grow in labs. Love does, too.


Author cupharmacy | Publish Date February 12, 2016
Full Story

Research    Faculty

Medical Marijuana Decreases Migraines

A new study, conducted by faculty members from our school and published online ahead of print in the January edition of Pharmacotherapy, reveals that patients diagnosed with migraine headaches saw a significant drop in migraine occurrences when treated with medical marijuana.  


Author cupharmacy | Publish Date February 01, 2016
Full Story

Research    Faculty

Antibiotic Resistance with Dr. O'Bryant

Pharmacy Practice News recently published an article about antibiotic resistance and the dangers of over-prescribing medications. Dr. Cindy O’Bryant talks to us about why it matters.


Author cupharmacy | Publish Date November 23, 2015
Full Story

Research    Students

P-3's Delve into Real-Life Research

CU’s Skaggs School of Pharmacy’s annual research poster presentation featured great research from nearly 200 P-3 students on Tuesday, Oct. 27. The exhibit, which is a collaborative effort between the Departments of Pharmaceutical Sciences and Clinical Pharmacy, allows students the opportunity to conceptualize research ideas and create practical pharmaceutical solutions to real-world problems. Forty groups presented posters on topics ranging from substance abuse to cancer.


Author cupharmacy | Publish Date November 03, 2015
Full Story

Research    Faculty

Research Retreat a Huge Success

This year, about 140 faculty, trainees and lab personnel from the CU Skaggs School of Pharmacy and Pharmaceutical Sciences attended the 2nd annual school-wide research retreat at Beaver Run Resort in Breckenridge. The retreat, held Aug. 5-7, featured a variety of sessions and programs ranging from genetics and genome packaging to vaccines and bioinformatics. Presentations were given by faculty, post docs and graduate students from the school including speakers from outside the school.


Author cupharmacy | Publish Date September 21, 2015
Full Story

Research    Faculty

Home visit program for kids with asthma reduces costs

Wheezing. Coughing. Inability to catch one's breath.

These are all symptoms of asthma. And for years those with asthma have relied upon inhalers and steroids to help reduce those symptoms and make breathing easier. But medications may be only part of the solution, especially in children with poorly controlled asthma.


Author cupharmacy | Publish Date August 31, 2015
Full Story

Research    Students

Science undergrads given helping hand by faculty

“I felt so far behind,” says 21-year-old Deedee Romo about her chances of getting into graduate school.

Now, this first generation Mexican-American is on her way to a very impressive med school application thanks to the Colorado Undergraduate Research in Environmental Health Sciences (CUrehs) program.


Author cupharmacy | Publish Date August 20, 2015
Full Story

Research    Faculty

Is there a natural cure for cancer?

If there is a natural cure for cancer, it may come from the laboratory of Rajesh Agarwal, PhD, professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences, and co-leader Cancer Prevention & Control Program at the CU Cancer Center. Agarwal has built a career dissecting the molecules inside natural products such as milk thistle, grape seed extract and bitter melon.


Author cupharmacy | Publish Date June 22, 2015
Full Story

Research    Faculty

Screening Potential Drugs – Thousands of Compounds at a Time

Reprinted from an article in the Aurora Sentinel by Brandon Johansson


Author cupharmacy | Publish Date March 02, 2015
Full Story

School of Pharmacy In the News

Medical Xpress

Common antibiotic can safely be given to most surgery patients despite penicillin allergy

news outletMedical Xpress
Publish DateMarch 17, 2021

"We found that that avoidance of cefazolin based on 50-year-old data is unnecessary and, in many cases, ill-advised," says senior author Meghan Jeffres, PharmD, with the University of Colorado Skaggs School of Pharmacy. "Not only is cefazolin safe for nearly all patients with penicillin allergy, but also, studies have shown that it's well tolerated and has the appropriate spectrum of activity against organisms commonly encountered in surgical site infections."

Full Story
KOAA

Opioid legal settlement brings millions of dollars to Colorado to battle crisis

news outletKOAA
Publish DateFebruary 09, 2021

Judy Solano of the Colorado Consortium for Prescription Drug Abuse, spoke with KOAA about the millions of dollars will soon be headed into Colorado communities to help fight the opioid epidemic thanks to a major legal settlement with a company involved in the promotion of these prescription drugs.

Full Story
CBS4 Denver

CBS4 Health Specialist Kathy Walsh Volunteers For Novavax COVID Vaccine Clinical Trial

news outletCBS4 Denver
Publish DateJanuary 12, 2021

P4 Eric Hartsfield is working as an intern at the VA Hospital at CUAnschutz, where a Novavax COVID-19 vaccine trial is taking place. Eric recently administered a shot to CBS4 Health Specialist Kathy Walsh who chronicled her experience

Full Story
Colorado Times-Reporter

Colo Lawmaker Won’t Get COVID Vaccine, Instead Takes Equine Deworming Meds

news outletColorado Times-Reporter
Publish DateJanuary 07, 2021

Professor David Kroll served as the featured expert in an article on a state representative who is encouraging followers to use ivermectin, instead of a vaccine to prevent against COVID-19 infection. Ivermectin is an anti-parasitic drug widely used for livestock and pets

Full Story